UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Transaminasen

MMW Fortschritte der Medizin, 2021-05, Vol.163 (9), p.51-51

Zachoval, Reinhart

2021

Volltextzugriff (PDF)

Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules

PloS one, 2014-08, Vol.9 (8), p.e105703-e105703

2014

Volltextzugriff (PDF)

Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort

PloS one, 2015-08, Vol.10 (8), p.e0135807-e0135807

2015

Volltextzugriff (PDF)

Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease

PloS one, 2013-03, Vol.8 (3), p.e58955-e58955

2013

Volltextzugriff (PDF)

Recurrence of hepatitis C virus after loss of virus-specific CD4 + T-cell response in acute hepatitis C

Gastroenterology (New York, N.Y. 1943), 1999-10, Vol.117 (4), p.933-941

1999

Volltextzugriff (PDF)

Hepatitis C Virus Infection and Injection Drug Users: Prevention, Risk Factors, and Treatment

Clinical infectious diseases, 2005-04, Vol.40 (Supplement-5), p.S330-S335

2005

Volltextzugriff (PDF)

YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis

Scandinavian journal of gastroenterology, 2011-11, Vol.46 (11), p.1369-1380

2011

Volltextzugriff (PDF)

Nucleosomal DNA Fragments in Autoimmune Diseases

Annals of the New York Academy of Sciences, 2006-09, Vol.1075 (1), p.318-327

2006

Volltextzugriff (PDF)

Chronic Hepatitis C - Therapeutic Options in 2016

MMW Fortschritte der Medizin, 2016-06, Vol.158 Suppl 1, p.54-57

2016

Volltextzugriff (PDF)

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Journal of hepatology, 2017-11, Vol.67 (5), p.918-924

2017

Volltextzugriff (PDF)

Symptoms and Occurrence of Hepatitis E in Solid-Organ Recipients: A Single-Center Experience of the Last Five Years: PUB292

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.847-847

2021

Volltextzugriff (PDF)

Aktuelle Therapieoptionen bei chronischer Hepatitis C

MMW Fortschritte der Medizin, 2016-06, Vol.158 (Suppl 2), p.54-58

2016

Volltextzugriff (PDF)

Serum cortisol/cortisone ratio after Synacthen stimulation

Clinical biochemistry, 2001-07, Vol.34 (5), p.421-425

2001

Volltextzugriff (PDF)

Intrahepatic diffuse periportal enhancement patterns on hepatobiliary phase gadoxetate disodium-enhanced liver MR images: Do they correspond to periportal hyperintense patterns on T2-weighted images?

Medicine (Baltimore), 2019-03, Vol.98 (11), p.e14784-e14784

2019

Volltextzugriff (PDF)

Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction

The Journal of experimental medicine, 2014-09, Vol.211 (10), p.2047-2059

2014

Volltextzugriff (PDF)

HEPATITIS B VACCINATION: HOW LONG DOES PROTECTION LAST?

The Lancet (British edition), 1984-08, Vol.324 (8400), p.458-458

1984

Volltextzugriff (PDF)

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance

Gastroenterology (New York, N.Y. 1943), 2003-07, Vol.125 (1), p.80-88

2003

Volltextzugriff (PDF)

Inhibitory Molecules That Regulate Expansion and Restoration of HCV-Specific CD4+ T Cells in Patients With Chronic Infection

Gastroenterology (New York, N.Y. 1943), 2011-10, Vol.141 (4), p.1422-1431.e6

2011

Volltextzugriff (PDF)

Non-invasive assessment of liver changes in Eisenmenger patients

International journal of cardiology, 2017-12, Vol.249, p.140-144

2017

Volltextzugriff (PDF)

The role of graft-resident Kupffer cells and lymphocytes of donor type during the time course after liver transplantation: a clinico-pathological study

Virchows Archiv : an international journal of pathology, 2003-10, Vol.443 (4), p.541-548

2003

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieHepatology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Englisch
(77)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Transaminasen

Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules

Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort

Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease

Recurrence of hepatitis C virus after loss of virus-specific CD4 + T-cell response in acute hepatitis C

Hepatitis C Virus Infection and Injection Drug Users: Prevention, Risk Factors, and Treatment

YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis

Nucleosomal DNA Fragments in Autoimmune Diseases

Chronic Hepatitis C - Therapeutic Options in 2016

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Symptoms and Occurrence of Hepatitis E in Solid-Organ Recipients: A Single-Center Experience of the Last Five Years: PUB292

A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B

Aktuelle Therapieoptionen bei chronischer Hepatitis C

Serum cortisol/cortisone ratio after Synacthen stimulation

Intrahepatic diffuse periportal enhancement patterns on hepatobiliary phase gadoxetate disodium-enhanced liver MR images: Do they correspond to periportal hyperintense patterns on T2-weighted images?

Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction

TOP-110 - Increasing functional cure rate beyond 96 weeks after discontinuation of nucleos (t)ide analogue treatment in HBeAg-negative chronic hepatitis B: follow-up of the stop-NUC trial

Increasing functional cure rate beyond 96 weeks after discontinuation of nucleos (t)ide analogue treatment in HBeAg-negative chronic hepatitis B: follow-up of the stop-NUC trial

HEPATITIS B VACCINATION: HOW LONG DOES PROTECTION LAST?

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance

Inhibitory Molecules That Regulate Expansion and Restoration of HCV-Specific CD4+ T Cells in Patients With Chronic Infection

Non-invasive assessment of liver changes in Eisenmenger patients

Response to discontinuation of long-term nucleos(t)ide analogue treatment in HBeAg negative patients: Results of the Stop-NUC trial

LBO06 - Response to discontinuation of long-term nucleos(t)ide analogue treatment in HBeAg negative patients: Results of the Stop-NUC trial

The role of graft-resident Kupffer cells and lymphocytes of donor type during the time course after liver transplantation: a clinico-pathological study

Aktive Filter

Suchergebnisse filtern